The role of infection in asthma;Infecção na modulaçâo da asma

Revista Portuguesa de Pneumologia

Volumn 14, Issue 5, 2008, Pages 647-675

  Mendes, J Pinto ^a  

^a NONE

Author keywords

Asthma and infection; Asthma and virus; Endotoxins

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ENDOTOXIN; EOTAXIN; IMMUNOGLOBULIN E; INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; RANTES; TOLL LIKE RECEPTOR;

ALLERGIC REACTION; ANTIBODY PRODUCTION; ASTHMA; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHLAMYDOPHILA PNEUMONIAE; CORONAVIRUS; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; ENVIRONMENTAL IMPACT; EOSINOPHILIA; GENETIC POLYMORPHISM; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN METAPNEUMOVIRUS; HYPOTHESIS; IMMUNE RESPONSE; MEDICAL RESEARCH; MYCOPLASMA PNEUMONIAE; NEUTROPHIL; NONHUMAN; PARVOVIRUS; PERINATAL PERIOD; PERSONAL HYGIENE; PHENOTYPE; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; SENSITIZATION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PYOGENES; TH1 CELL; TH2 CELL; TORQUE TENO VIRUS; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS VIRULENCE; BACTERIUM; HYPERSENSITIVITY; METABOLISM;

ASTHMA; BACTERIA; BACTERIAL INFECTIONS; HUMANS; HYPERSENSITIVITY; VIRUS DISEASES;

EID: 58249091335     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30275-0     Document Type: Review

References (114)

1. Pelaia A, Varrella R, Galleli L. et al. Respiratory infections and asthma.Respir Med 2006; 100:775 -84.
2. Lemanske RF. Viral infections and asthma inception. J Allergy Clin Immunol 2004; 114:1023-26.
3. Johnston SI, Pattermore Pk, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 years old children. BMJ 1995; 1225-29.
4. Copenhauer Cc, Gern Ge, Li Z, et al. Cytokine response patterns, exposure to viruses and respiratory infection in the first year of life. Am J Respir Crit Care Med 2004;170:175-80.
5. Nicholson KG, Kent J, Ireland DC. Respiratory virus and exacerbations of asthma in adults. BMJ 1993; 307: 982-86.
6. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005; 116: 267-73.
7. Empey DW, Laitinen LA, Jacobs L, et al. Mechanics of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131-39.
8. Stokes GM, Milner AD, Hodges IGC, Grobbins RC. Lung function abnormalities after acute bronchiolitis. J Pediatr, 1981; 98:871-74.
9. Haal CB, Halol WJ, Gala CL, et al. Long -term prospective study of children after respiratory syncytial virus infection. J Pediatr 1984; 105:358-64.
10. Martin JG, Diddiqui S, Hassan M. Immune responses to viral infections: relevance for asthma. Ped Respir Rev 2006; 75: S125-S127.
11. Van den Hoogen BG, De Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7:719-24.
12. Van der Hoek L, Pyrc K, Jerbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10:368-73.
13. Woo PC, Lau SK, Chu SM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKV1, from patients with pneumonia. J Virol 2005; 79:884-95.
14. Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 2005; 102: 12891-6.
15. Pifferi M, Maggi F, Andreoli E, et al. Associations between torquetenovirus load and spirometric indices in children with asthma. J Infect Dis 2005; 192:1141-8.
16. Freymuth F, Vabret A, Galateau-Salle F, et al. Detection of respiratory syncytial virus, parainfluenza 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridization. Clin Diagn Virol 1997;8:31-40.
17. Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev 2004; 5 (Suppl. A): 223-38.
18. Lemanske RF. Is asthma an infectious disease? Chest 2003; 3: S385-S390.
19. Weinberger M. Respiratory infections and asthma: current treatment strategies. Drug Discovery Today 2004; 9: 831-7.
20. Sigurs N, Bjamason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161: 1501-7.
21. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003; 22:76-82.
22. Holt PG, Sly PD. Interactions betweem RSV infection, asthma and atopy. Unraveling the complexities. J Exp Med 2005; 196:1271-5.
23. Husel MMH, De Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105-10.
24. Hersoug L-G. A reformulation of the hygiene hypothesis: maternal infeccious diseases confer protection against asthma in the infant? Medical Hypothesis 2006; 27: 717-20.
25. Darkham A, Mok Lee Y, Gelfand EW. Virus-induced airway dysfunction. Pathogenesis and biomechanisms. Ped Infect Dis J 2005; 24(Suppl):S159-S169.
26. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171:137-41.
27. Stein R, Sherrill D, Morgan W, et al. Respiratory syncycial virus in early life and risk of wheeze and allergy by age of 13 years. Lancet 1999; 354:541-45.
28. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory virus in mice. J Clin Invest 1991; 88:1026-33.
29. Dakhama A, Park JW, Taube C, et al. Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following syncytial virus infection. Am J Physiol Lung Cell Mol Physiol, 2005; 228: L761-L770.
30. Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory virus by nasally administered siRNA. Nat Med 2005; 11:50-5.
31. Zhang W, Yang H, Kong X, et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 2005; 11:56-62.
32. Lemanske RF, Jackson DJ, Gangnon RE, et al. Rhinovirus illness during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol, 2005; 116: 571-7.
33. Tan WC. Virus in asthma exacerbations. Curr Opin Pulm Med 2005; 11:21-6.
34. Almstrom K, Pitkäranta A, Carpen O, et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 2006; 118:591-6.
35. Holgate ST. Rhinovirus in the pathogenesis of asthma: the bronchial epithelium as a major disease target. J Allergy Clin Immunol 2006; 118:587-90.
36. Cheung D, Dick EC, Timmers MC, et al. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995; 152: 1490-6.
37. Grungerg K, Timmers MC, De Klerk EP, et al. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999; 160:1375-80.
38. Calvani M, Alessandri C, Bonci E. Fever episodes in early life and the development of atopy in children with asthma. Eur Respir J 2002; 20:391-6.
39. Korppi M, Piippo-Savolainen E, Korhonen K, Remess S. Respiratory morbidity 20 years after SRV in infancy. Pediatr Pulmonol 2004; 38:155-60.
40. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994; 94: 2220-8.
41. Schwarze J, Gelfand EW. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur Respir J 2002; 19:341-9.
42. Makela MJ, Tripp R, Dakhama A, et al. Prior airway exposure to allergen increases virus -induced airway hyperresponsiveness. J Allergy Clin Immunol 2003; 112: 861-9.
43. Schaller M, Hogaboam CM, Wkaks N, Kunkez SL. Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response. J Allergy Clin Immunol 2006; 118:295-302.
44. Randolph DA, Carruthers CJ, Szabo SJ, et al. Modulation of airway inflammation by passive transfer of allergen -specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162: 23755-83.
45. Umetsu DT, Abkari V, Dekruyff R. Regulatory T cells control of allergic disease and asthma. J Allergy Clin Immunol 2003; 117:480-7.
46. Lee RM, White MR, Hartshorn KL. Influenza A viruses upregulate neutrophil Toll-like Receptor 2 expression and function. Scandinavian J Immunol 2006; 63: 81-9.
47. Pala P, Bjarnason R, Sigurbergsson F, et al. Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy. Eur Respir J 2002; 20: 370-82.
48. Choi EH, Lee HJ, Yoo T, Chanock ST. A common haplotype of interleukin 4 gene is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002; 186:1207-11.
49. Jackson M, Scott R. Distinct patterns of cytokine induction in cultures of respiratory syncytial (RS) virus -specific humam Th cell lines following stimulation with RS virus and RS virus proteins. J Med Virol 1996; 49:161-9.
50. Cochran JR, Khan AM, Elidmir O, et al. Influence of LPS exposure on airway function and allergic responses in developing mice. Pediatr Pulmonol 2002; 34:267-77.
51. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1-4.
52. Henson CA, Jardine A, Edwards MR, et al. Toll-like Receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005; 79:12 273-9.
53. Schaub B, Lavener R, Von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2006; 117:967-77.
54. Wark PAB, Johnston SL, Bucchieri F. et al. Asthmatic bronchial epithelial cells have a deficient innate response to infection with rhinovirus. J Exp Med 2005; 210:937-47.
55. Van Rijt LS, Van Kessel G, Boogaard I, Lambrecht BN. Respiratory viral infections and asthma pathogenesis: a critical role for dendritic cells? J Clin Virol 2005; 34:161-9.
56. Mazzoni A, Leifer CA, Mullen GE, et al. Cutting edge: histamine inhibits IFN. alpha release from plasmacytoid dendritic cells. J Immunol 2003; 170:2269-73.
57. Zuniga EI, Mc Gavern DB, Pruneda-Paz JL ET, et al. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 2004; 5:1227-34.
58. Kalina WW, Gershwin LJ. Progress in defining the role of RSV in allergy and asthma. Clin Rev Immunol 2004; 11:113-9.
59. Remes ST, Korppi M. On roots of childhood asthma: the role of respiratory infections. Ann Med 2005; 37:26-32.
60. Prescott SL, Björkstén G. Probiotic for the prevention of treatment or allergic diseases. J Allergy Clin Immunol 2007; 120:255-62.
61. Strachan DP. Hay fever, hygiene and household size. BMJ 1989; 299:1259-60.
62. Peat J, Björksten B. Primary and secondary prevention of allergic asthma. Eur Respir J 1988; 27 (Suppl): 28S-34S.
63. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999; 354 (Suppl 2): 112-5.
64. Liu AH, Murphy JR. Hygiene hypothesis: fact or fiction? J Allergy Clin Immunol 2003; 111:471-8.
65. Von Mutius , Illi S, Hirsch T, et al. Frequency of infections in the first years of life and risk of asthma, atopy and airway hyperresponsiveness among schoolage children. Eur Respir J 1999; 14:4-11.
66. Linehan MF, Fr4ank TL, Hazell ML, et al. Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J Allergy Clin Immunol 2007; 119:1079-85.
67. Aligne CA, Auinger P, Byrd RS, Weitzman M. Risk factors for pediatric asthma. Contributions of poverty, race and urban residence. Am J Respir Crit Care Med 2000; 162: 873-7.
68. Yazdanbarkhsh M, Kremsner PG, Van Ree R. Allergy, parasites and hygiene hypothesis. Science 2000; 296: 490-4.
69. Tantisara KG, Weiss ST. Childhood infections and asthma: at the crossroad of the hygiene and Barker hypothesis. Respir Res 2001; 2:324-7.
70. Bryan SA, O'Connor BJ, Chung KF, et al. Effects of an antileukin-12 on eosinophils, airway hyperresponsiveness, and the late asthmatic reaction. Lancet 2000; 356:2148-53.
71. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-20.
72. Hansen G, Berry G, De Kruiff R, Umetsu D. Allergen-specific Th1 cells fails to counterbalance Th2 cell induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-83.
73. Dahl ME, Dabbagh K, Liggit D, et al. Viral-induced T helper type1 responses enhance allergic disease by effects of lung dendritic cells. Nat Immunol 2004; 5:337-43.
74. Jeon SG, Oh S-Y, Park H-K, et al. Th2 and Th1 lung inflammation induced by airway allergen sensitization with low and high dose of double. stranded RNA. J Allergy Clin Immunol 2007; 120:803-12.
75. Holtzman NJ, Morton JD, Shornick LP, et al. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral. allergic paradigm. Physiol Rev 2002; 82: 19-46.
76. Bachettaa R, Gambineri E, Roncarolo M-G. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007; 120:227-35.
77. Larché M. Regulatory T cells in allergy and asthma. Chest 2007; 132: 1607-14.
78. Romagnani S. Coming back to a missing immune deviation as the main exploratory mechanisms for the hygiene hypothesis. J Allergy Clin Immunol 2007; 119: 1511-13.
79. Canonica G, Ciprandi G, Pesce G, et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995; 107: 99-102.
80. Chmidt -Weber CB, Akdis M, Akdis CA. Th17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120:247-54.
81. Hersoug L-G. A reformulation of the hygiene hypothesis: maternal infectious diseases confer protection against asthma in the infant? Medical Hypotheses 2006; 27:717-20.
82. Gehring U, Bolte G, Borte M, et al. Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study. J Allergy Clin Immunol 2001; 108: 847-54.
83. Braun-Fahrlander C, Riedler J, Herz U, et al. The Allergy and Endotoxin Study Team. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-77.
84. Martinez FD. CD14, endotoxin and asthma risk. Actions and interactions. Proc Am Thorac Soc 2007; 4: 221-25.
85. Riedler J, Eder W, Schrever M, et al. Early life exposure to farming provides protection against the development of asthma and allergy. Lancet 2001;358:129-33.
86. Von Mutius E. Asthma and allergies in rural areas of Europe. Proc Am Thoracic Soc 2007; 4:212-6.
87. Molson T, Bronchi L, Hessen J, et al. Asthma and indoor environment in Nepal. Thorax 2001; 56: 477-81.
88. Vedantham PK, Maesh PA, Vedanthan R, et al. Effect of animal contact and microbial exposures in the prevalence of atopy and asthma in urban vs rural children in India. Ann Allergy Asthma Immunol 2006; 96: 571-8.
89. Reefer AJ, Carneiro RM, Custis NJ, et al. A role for IL-10 mediated HLA. DR7 -restricted T-cell-dependent events in the development of the modified Th2 response to cat allergen. J Immunol 2004; 172: 2763-72.
90. Platts-Mills JA, Custis NJ, Woodfock A, Platts-Mills TAE. Airborne endotoxin in homes with domestic animals: implication for cat specific tolerance. J Allergy Clin Immunol 2005; 116: 384-9.
91. Crellin NK, Garcia RV, Hadisfar O, et al. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+ CD25+ T regulatory cells. J Immunol 2005; 175: 8051-9.
92. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004; 112:352-63.
93. Simpson A, John SL, Jury F, et al. Endotoxin exposure, CD14, and allergic disease. An association between genes and the environment. Am J Resp Crit Care Med 2006; 174:386-92.
94. Hopelman GH. Gene environment interaction in allergic disease: more questions, more answers? J Allergy Clin Immunol 2007; 120:1266-8.
95. Kaisho T, Alkira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006; 117: 979-87.
96. Lavener RP, Birchler T, Adamski J, et al. Expression of CD14 and Toll-like receptor 2 in farmers and non-farmers children. Lancet 2002; 360: 465-6.
97. Ege MJ, Frei R, Bieli C, et al. (Parsifal Study). Not all farming environments protect against the development of asthma and wheeze in children. J Allergy Clin Immunol 2007; 119: 1140-7.
98. Eder W, Von Mutius E. Hygiene hypothesis and endotoxin: what is the evidence? Curr Opin Allergy Clin Immunol 2004; 4:113-7.
99. Portegen L, Preller L, Tielen M, et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113:482-8.
100. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 2002; 109:379-92.
101. Reed CE, Milton DK. Endotoxin-stimulated innate immunity: a contributing factor for asthma. J Allergy Clin Immunol 2001; 108:157-66.
102. Douwes J, Pearce N, Heederk D. Does environmental endotoxin exposure prevents asthma? Thorax 2002; 57:86-90.
103. Park JH, Gold DR, Spiegelman DL, et al. House dust endotoxin and wheeze in the first year of life. Am J Respir Crit Care Med 2001; 163:322-8.
104. Eder W, Klimeri W, Yu L, et al. The Allergy and Endotoxin (ALEX) Study Team. Opposite effects of CD14/. 260 on serum IgE levels in children raised in different environments. J Allergy Clin Immunol 2005; 116:601-7.
105. Gern JE, Reardon CL, Hoffman A, et al. Effects of dog ownership and genotype in immune development and atopy in infancy. J Allergy Clin Immunol 2004; 113: 307-14.
106. Bieli C, Eder W, Frei M, et al. A polymorphism in cd14 modified the effect of farm milk consumption on allergic disease and CD14 gene expression. J Allergy Clin Immunol 2007; 120:1308-15.
107. Weiss ST. Association studies in asthma genetics. Am J Respir Crit Care Med 2001; 164:2014-5.
108. Baldini M, Lohman Ic, Halonen M, et al. A polymorphism in the 5′. flanking region of the CD14 gene is associated with circulating soluble CD14 levels and total serum IgE. Am J Respir Cell Mol Biol 1999; 20:976-83.
109. Los H, Koppelman GH, Postma DS. The importance of genetic influences in asthma. Eur Respir J 1999; 14:1210-27.
110. Ulevitch RJ, Tobias PS. Dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13:437-57.
111. Pigliuci M, Schlichting C. Phenotypic evolution: a reaction norm perspective. Sunderland, MA: Sinauer Associates, Inc 1996.
112. Kim Y-K, Oh S-Y, Jeon SG, et al. Airway exposure levels of lypopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 2007; 178: 5375-82.
113. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo. controlled study. Lancet 2003; 361: 1869-71.
114. Celedon JC, Litonjua AA, Ryan L, et al. Lack of association between antibiotic use in the first year of life and asthma, allergic rhinitis, or eczema at age of 5 years. Am J Respir Crit Care Med 2002; 166: 72-5.